BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9348249)

  • 1. Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants.
    Gottvall T; Hildén JO
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):733-8. PubMed ID: 9348249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newborn.
    Gottvall T; Hildén JO; Selbing A
    Acta Obstet Gynecol Scand; 1994 Apr; 73(4):300-6. PubMed ID: 8160535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of maternal anti-D concentrations during pregnancy.
    Filbey D; Berseus O; Sandström B; Wesström G
    Early Hum Dev; 1987 Jan; 15(1):1-9. PubMed ID: 3102209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rh-D antibody titer in amniotic fluids. Its use as an index of the severity of erythroblastosis fetalis.
    Usategui-Gomez M; Stearns SB; Toolan HW
    Am J Obstet Gynecol; 1969 Dec; 105(8):1238-46. PubMed ID: 4982810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of the degree of fetal injury by the Rh antibody titer in the amniotic fluid].
    Vitanova R
    Akush Ginekol (Sofiia); 1985; 24(1):43-7. PubMed ID: 3925801
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
    Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
    Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important variations of maternal anti-Rhesus (D) antibody level during two consecutive pregnancies without antigenic stimulus.
    Moncharmont P; Juron-Dupraz F; Rigal D; Meyer F
    Acta Haematol; 1990; 83(2):105-6. PubMed ID: 2106193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interrelationship between the Rh antibody titer in the amniotic fluid and its spectrophotometric study].
    Vitanova R
    Akush Ginekol (Sofiia); 1985; 24(2):43-8. PubMed ID: 3925804
    [No Abstract]   [Full Text] [Related]  

  • 11. The evaluation of extended analysis of serum, amniotic fluid and cardiotocography in the management of pregnancy complicated by immunization in Rh or Kell antigens.
    Woytoń J; Narczewska B; Gajewska E; Baranowski H; Kwoczyńska K; Dzierzkowa-Borodej W; Partyka T; Bochenek S; Lochocka E
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1131-7. PubMed ID: 107916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-D (Rh) antibodies in the amniotic fluid].
    Bianchi R; Hille A; Cabrera F; Rojas E
    Rev Chil Obstet Ginecol; 1973; 38(4):172-5. PubMed ID: 4219858
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of anti-Rh antibodies in amniotic fluid].
    Benoit P; Gagnon M; Doray BH; Bonin A; Bertrand R
    Union Med Can; 1972 Jan; 101(1):58-64. PubMed ID: 4622396
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemolytic disease of the newborn due to rare alloantibodies.
    Zuliani G; Moroni GA; Buscaglia M; Morotti R; Pardi G
    Ric Clin Lab; 1983; 13(4):449-57. PubMed ID: 6419339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A management programme for Rh alloimmunization during pregnancy.
    Filbey D; Berseus O; Lindeberg S; Wesström G
    Early Hum Dev; 1987 Jan; 15(1):11-20. PubMed ID: 3102210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
    van Dijk BA; Hirasing RA; Overbeeke MA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemolytic disease of the newborn due to anti-Ce.
    Malde R; Stanworth S; Patel S; Knight R
    Transfus Med; 2000 Dec; 10(4):305-6. PubMed ID: 11123814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
    Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Anti-D titers in RhD-negative pregnant women on fetuses and newborns: A retrospective study.
    Tang TH; Guo CY; Li XY; Hu YX; Liu WK; Yu MX
    Pediatr Neonatol; 2024 May; 65(3):288-292. PubMed ID: 37957047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the Rh-D antibody titres of amniotic fluids and corresponding maternal sera in Rh-D sensitized pregnancies.
    Usategui-Gomez M; Stearns S
    Nature; 1969 Jan; 221(5175):82-3. PubMed ID: 4973138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.